Best Practice & Research Clinical Haematology
Volume 20, Issue 3 , Pages 415-424 , September 2007

The B-cell receptor and ZAP-70 in chronic lymphocytic leukemia

References 

  1. Fais F, Ghiotto F, Hashimoto S, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. The Journal of Clinical Investigation. 1998;102(8):1515–1525
  2. Hamblin TJ, Davis Z, Gardiner A, et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94(6):1848–1854
  3. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94(6):1840–1847
  4. Maloum K, Davi F, Merle-Beral H, et al. Expression of unmutated VH genes is a detrimental prognostic factor in chronic lymphocytic leukemia. Blood. 2000;96(1):377–379
  5. Kipps TJ, Rassenti LZ, Duffy S, et al. Immunoglobulin V gene expression in CD5 B-cell malignancies. Annals of the New York Academy of Sciences. 1992;651:373–383
  6. Hashimoto S, Dono M, Wakai M, et al. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells. The Journal of Experimental Medicine. 1995;181(4):1507–1517
  7. Johnson TA, Rassenti LZ, Kipps TJ. Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. Journal of Immunology. 1997;158(1):235–246
  8. Widhopf GF, Rassenti LZ, Toy TL, et al. Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood. 2004;104(8):2499–2504
  9. Widhopf GF 2nd, Goldberg CJ, Toy TL, et al. Non-stochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3. Blood (in press).
  10. Rosenwald A, Alizadeh AA, Widhopf G, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. The Journal of Experimental Medicine. 2001;194(11):1639–1647
  11. Klein U, Tu Y, Stolovitzky GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. The Journal of Experimental Medicine. 2001;194(11):1625–1638
  12. Klein U, Dalla-Favera R. New insights into the phenotype and cell derivation of B cell chronic lymphocytic leukemia. Current Topics in Microbiology and Immunology. 2005;294:31–49
  13. Chen L, Widhopf G, Huynh L, et al. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. Blood. 2002;100(13):4609–4614
  14. Rassenti LZ, Huynh L, Toy TL, et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. The New England Journal of Medicine. 2004;351(9):893–901
  15. Crespo M, Bosch F, Villamor N, et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. The New England Journal of Medicine. 2003;348(18):1764–1775
  16. Orchard JA, Ibbotson RE, Davis Z, et al. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet. 2004;363(9403):105–111
  17. Nuckel H, Huttmann A, Klein-Hitpass L, et al. Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia. Leukemia & lymphoma. 2006;47(6):1053–1061
  18. Taniguchi T, Kobayashi T, Kondo J, et al. Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis. The Journal of Biological Chemistry. 1991;266(24):15790–15796
  19. Chan AC, Iwashima M, Turck CW, et al. ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain. Cell. 1992;71(4):649–662
  20. Qian D, Weiss A. T cell antigen receptor signal transduction. Current Opinion in Cell Biology. 1997;9(2):205–212
  21. Kane LP, Lin J, Weiss A. Signal transduction by the TCR for antigen. Current Opinion in Immunology. 2000;12(3):242–249
  22. Chan AC, van Oers NS, Tran A, et al. Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling. Journal of Immunology. 1994;152(10):4758–4766
  23. Law CL, Sidorenko SP, Chandran KA, et al. Molecular cloning of human Syk. A B cell protein-tyrosine kinase associated with the surface immunoglobulin M-B cell receptor complex. The Journal of Biological Chemistry. 1994;269(16):12310–12319
  24. Kong GH, Bu JY, Kurosaki T, et al. Reconstitution of Syk function by the ZAP-70 protein tyrosine kinase. Immunity. 1995;2(5):485–492
  25. Toyabe S, Watanabe A, Harada W, et al. Specific immunoglobulin E responses in ZAP-70-deficient patients are mediated by Syk-dependent T-cell receptor signalling. Immunology. 2001;103(2):164–171
  26. Fu C, Turck CW, Kurosaki T, et al. BLNK: a central linker protein in B cell activation. Immunity. 1998;9(1):93–103
  27. Ishiai M, Kurosaki M, Pappu R, et al. BLNK required for coupling Syk to PLC gamma 2 and Rac1-JNK in B cells. Immunity. 1999;10(1):117–125
  28. Kabak S, Skaggs BJ, Gold MR, et al. The direct recruitment of BLNK to immunoglobulin alpha couples the B-cell antigen receptor to distal signaling pathways. Molecular and Cellular Biology. 2002;22(8):2524–2535
  29. Kurosaki T, Tsukada S. BLNK: connecting Syk and Btk to calcium signals. Immunity. 2000;12(1):1–5
  30. Jumaa H, Bossaller L, Portugal K, et al. Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia. Nature. 2003;423(6938):452–456
  31. Kurosaki T, Maeda A, Ishiai M, et al. Regulation of the phospholipase C-gamma2 pathway in B cells. Immunological Reviews. 2000;176:19–29
  32. Hivroz C, Grillot-Courvalin C, Brouet JC, et al. Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2. European Journal of Immunology. 1986;16(8):1001–1004
  33. Lankester AC, van Schijndel GM, van der Schoot CE, et al. Antigen receptor nonresponsiveness in chronic lymphocytic leukemia B cells. Blood. 1995;86(3):1090–1097
  34. Kipps TJ. Signal transduction pathways and mechanisms of apoptosis in CLL B-lymphocytes: their role in CLL pathogenesis. Hematology and Cell Therapy. 1997;39(Suppl. 1):S17–S27
  35. Thompson AA, Talley JA, Do HN, et al. Aberrations of the B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia. Blood. 1997;90(4):1387–1394
  36. Payelle-Brogard B, Magnac C, Mauro FR, et al. Analysis of the B-cell receptor B29 (CD79b) gene in familial chronic lymphocytic leukemia. Blood. 1999;94(10):3516–3522
  37. Gordon MS, Kato RM, Lansigan F, et al. Aberrant B cell receptor signaling from B29 (Igbeta, CD79b) gene mutations of chronic lymphocytic leukemia B cells. Proceedings of the National Academy of Sciences of the United States of America. 2000;97(10):5504–5509
  38. Cragg MS, Chan HT, Fox MD, et al. The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis. Blood. 2002;100(9):3068–3076
  39. Semichon M, Merle-Beral H, Lang V, et al. Normal Syk protein level but abnormal tyrosine phosphorylation in B-CLL cells. Leukemia. 1997;11(11):1921–1928
  40. Michel F, Merle-Beral H, Legac E, et al. Defective calcium response in B-chronic lymphocytic leukemia cells. Alteration of early protein tyrosine phosphorylation and of the mechanism responsible for cell calcium influx. Journal of Immunology. 1993;150(8 Pt 1):3624–3633
  41. Lanham S, Hamblin T, Oscier D, et al. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. Blood. 2003;101(3):1087–1093
  42. Chen L, Apgar J, Huynh L, et al. ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia. Blood. 2005;105(5):2036–2041
  43. Witkowski JM, Zmuda-Trzebiatowska E, Swiercz JM, et al. Modulation of the activity of calcium-activated neutral proteases (calpains) in chronic lymphocytic leukemia (B-CLL) cells. Blood. 2002;100(5):1802–1809
  44. Karin M. NF-kappaB and cancer: mechanisms and targets. Molecular Carcinogenesis. 2006;45(6):355–361
  45. Claudio E, Brown K, Siebenlist U. NF-kappaB guides the survival and differentiation of developing lymphocytes. Cell Death and Differentiation. 2006;13(5):697–701
  46. Lucas PC, McAllister-Lucas LM, Nunez G. NF-kappaB signaling in lymphocytes: a new cast of characters. Journal of Cell Science. 2004;117(Pt 1):31–39
  47. Bernal A, Pastore RD, Asgary Z, et al. Survival of leukemic B cells promoted by engagement of the antigen receptor. Blood. 2001;98(10):3050–3057
  48. Del Principe MI, Del Poeta G, Buccisano F, et al. Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. Blood. 2006;108(3):853–861
  49. Latour S, Chow LM, Veillette A. Differential intrinsic enzymatic activity of Syk and Zap-70 protein-tyrosine kinases. The Journal of Biological Chemistry. 1996;271(37):22782–22790
  50. Zoller KE, MacNeil IA, Brugge JS. Protein tyrosine kinases Syk and ZAP-70 display distinct requirements for Src family kinases in immune response receptor signal transduction. Journal of Immunology. 1997;158(4):1650–1659
  51. Gobessi S, Laurenti L, Longo PG, et al. ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells. Blood. 2007;109(5):2032–2039
  52. Castro JE, Prada CE, Loria O, et al. ZAP-70 is a novel conditional heat shock protein 90 (Hsp90) client: inhibition of Hsp90 leads to ZAP-70 degradation, apoptosis, and impaired signaling in chronic lymphocytic leukemia. Blood. 2005;106(7):2506–2512

PII: S1521-6926(07)00046-1

doi: 10.1016/j.beha.2007.04.001

Best Practice & Research Clinical Haematology
Volume 20, Issue 3 , Pages 415-424 , September 2007

Article Tools

* Image Usage & Resolution